Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 9
2021 25
2022 14
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen YD, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D'Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK; BACC Bay Tocilizumab Trial Investigators. Stone JH, et al. Among authors: d silva km. N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21. N Engl J Med. 2020. PMID: 33085857 Free PMC article. Clinical Trial.
COVID-19 and Disease-Modifying Anti-rheumatic Drugs.
D'Silva KM, Wallace ZS. D'Silva KM, et al. Curr Rheumatol Rep. 2021 Apr 24;23(5):28. doi: 10.1007/s11926-021-00998-9. Curr Rheumatol Rep. 2021. PMID: 33893890 Free PMC article. Review.
COVID-19 and rheumatoid arthritis.
D'Silva KM, Wallace ZS. D'Silva KM, et al. Curr Opin Rheumatol. 2021 May 1;33(3):255-261. doi: 10.1097/BOR.0000000000000786. Curr Opin Rheumatol. 2021. PMID: 33625043 Free PMC article. Review.
Incident systemic rheumatic disease following COVID-19.
Hsu TY, D'Silva KM, Patel NJ, Fu X, Wallace ZS, Sparks JA. Hsu TY, et al. Among authors: d silva km. Lancet Rheumatol. 2021 Jun;3(6):e402-e404. doi: 10.1016/S2665-9913(21)00106-5. Epub 2021 Apr 6. Lancet Rheumatol. 2021. PMID: 33842894 Free PMC article. No abstract available.
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial.
Merrill JT, Tanaka Y, D'Cruz D, Vila-Rivera K, Siri D, Zeng X, Saxena A, Aringer M, D'Silva KM, Cheng L, Mohamed MF, Siovitz L, Bhatnagar S, Gaudreau MC, Doan TT, Friedman A. Merrill JT, et al. Among authors: d silva km. Arthritis Rheumatol. 2024 Oct;76(10):1518-1529. doi: 10.1002/art.42926. Epub 2024 Aug 7. Arthritis Rheumatol. 2024. PMID: 38923871 Clinical Trial.
Hypouricemia and Mortality Risk in the US General Population.
D'Silva KM, Yokose C, Lu N, McCormick N, Lee H, Zhang Y, Choi HK. D'Silva KM, et al. Arthritis Care Res (Hoboken). 2021 Aug;73(8):1171-1179. doi: 10.1002/acr.24476. Epub 2021 Jul 12. Arthritis Care Res (Hoboken). 2021. PMID: 33026684 Free PMC article.
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases.
Cook C, Patel NJ, D'Silva KM, Hsu TY, DiIorio M, Prisco L, Martin LW, Vanni K, Zaccardelli A, Todd D, Sparks JA, Wallace ZS. Cook C, et al. Among authors: d silva km. Ann Rheum Dis. 2022 Feb;81(2):289-291. doi: 10.1136/annrheumdis-2021-221326. Epub 2021 Sep 6. Ann Rheum Dis. 2022. PMID: 34489304 Free PMC article. No abstract available.
42 results